期刊文献+

心血管病人性功能障碍的康复(下) 被引量:5

Rehabilitation of sexual dysfunction in cardiovascular patients (Ⅱ)
下载PDF
导出
摘要 因为心血管病人伴性功能障碍者更常见,性功能障碍的治疗出现突破.心血管医师治疗勃起功能障碍的处方已处于非泌尿科医师的领先地位,心脏康复医师应掌握与此有关的知识和技术,改善患者的生活质量。因篇幅关系,分次刊登本文的:一、性功能障碍;二、心血管病人性活动减少;三、心血管病人性活动危险分层;四心血管病人恢复性活动的指征;五、降低性生活危险性的治疗;六、恢夏性功能;七、附录:勃起功能国际指数问卷等。本刊今年第4期291~296页刊登了本文的第一、二部分.现续登其它部分,供参考。 Because patients with sexual dysfunction were more frequent and treatment of sexual dysfunction appears to break through, prescriptions of sexual dysfunction wrote by cardiologist already placed in leading position of that of no-urologist. Thereby cardiologist must hold the techniques of sexual dysfunction treatment to ameliorate quality of life in cardiovascular patients. Because length of writing the 1st and 2nd portion of this text was published in Chinese Journal of Cardiovascular Rehabilitation Medicine, 2002.11 (4): 291 - 296. Now publish the other portion of this text.
作者 刘江生
出处 《心血管康复医学杂志》 CAS 2002年第6期483-494,502,共13页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 心血管病人 性功能障碍 康复 Cardiovascular disease Sexual dysfunction Rehabilitation
  • 相关文献

参考文献55

  • 1徐勤.有性生活,才叫正常[N]. 健康报,2000,7,6.
  • 2伍法同,万莉娟,刘凤英.云南长寿老人综合调查显示生活方式是影响长寿重要因素[N].健康报,2002,4,4.
  • 3Levine LA, Kloner RA.张凯译.问诊在勃起功能障碍(ED)诊治中的重要性[N].中国医学论坛报,2001,6,14.
  • 4Ahmed Fawzy.周立新,黄翼然译.西地那非治疗勃起功能障碍的效果和安全性[N].中国医学论坛报,2001,8,2.
  • 5Harin Padma-Nathan (马兰译). 勃起功能障碍的诊治进展[N].中国医学论坛报,2000,4,20.
  • 6峡江.日本男性的ED患病率稍高于美国[N].中国医学论坛报,1998,12,13.
  • 7全国男科学术会议(昆明)报道.男性勃起功能障碍研究新进展[N].中国医学论坛报,1999,11,25.
  • 8欧洲泌尿外科学会.(马兰译).勃起功能障碍诊疗指南[N].中国医学论坛报,2000,6,8.
  • 9Jardin A,Wagner G,Khoury S,等.勃起功能障碍诊治指南-第一届国际勃起功能障碍咨询委员会推荐[N].中国医学论坛报,2000,10,26.
  • 10Halin Padma-Nathan.勃起功能障碍的诊治进展[N].中国医学论坛报,2000,4,20.

二级参考文献30

  • 1[1]NIH Consensus Conference Impotence: NIH Consensus Development Panel onlmpotence[ J ]. JAMA, 1993,270:83-90.
  • 2[2]Shabsign R,Fishman IJ,Scott FB. Evaluation of erectile impotence [ J ]. Urology,1988,32:83-90.
  • 3[3]Fildman HA,Goldstein I,Hatzichristou DG,et al. Impotence and its medical andpsychosociaal correlates: results of the Massachusetts Male Aging Study [ J ]. JUro1,1994,151:54-61.
  • 4[4]Cheitlin MD,Hutter AM Jr,Brindis RG, et al. Use of sildenafil (Viagra) in patieuts with cardiovascular disease[ J ]. Circulation, 1999,99:168-177.
  • 5[5]Naylir AM. Endogenhous neurotransmitters mediating penile erection [ J ]. Br JUrol, 1998,81:424-431.
  • 6[6]Goldstein I,Lue TF,Padma-Nathan H,et al. Oral sildenafil in the treatment of erectile dysfunction[J]. N Engl J Med,1998,338:1397-1404.
  • 7[7]Packer M, Carver JR, Rodeheffer R J, et al. Effect of oral milrinone on mortalityin severe chronic heart failure:the PROMISE Study Research Group[J]. N EnglMed, 1991,325:1468-1475.
  • 8[8]Nony P,Boissel JP,Lievre M,et al. Evaluation of the effect of phosphodiesteraseinhibitons on mortality in chronic heart failure patients: a rmeta-analysis [ J ]. Eur JClin Pharmacol, 1994,46:191-196.
  • 9[9]Degerman E,Belfrage P,Manganiello VC. Structure,localization, and regulationof cGMP-inhibited phosphodiesterase [ J ]. J Biol Chem, 1997,272: 6823-6826.
  • 10[10]Anderson K, Stief C. Penile erection and cardiac risk:pathophysiologic andpharmacologic mechanisms[J]. Am J Cardiol,2000,86(2A) :23F-26F.

共引文献4

同被引文献18

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部